BioChemics, Inc. Report issue

For profit Phase 2
Founded: Danvers MA United States (1989)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2011
NCT01496326
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

bc-dn-01 (1 trial)

ibuprofen (motrin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Neuropathies (Phase 2)

Osteoarthritis (Phase 2)

Pain (Phase 2)

Peripheral Nervous System Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2